Systemic action of human growth hormone following adenovirus-mediated gene transfer to rat submandibular glands

Gene Therapy

Volumn 5, Issue 4, 1998, Pages 537-541

  He, X ^a   Goldsmith, C M ^a   Marmary, Y ^a   Wellner, R B ^a   Parlow, A F ^b   Nieman, L K ^c   Baum, B J ^a,d  

^a NATIONAL INSTITUTE OF DENTAL AND CRANIOFACIAL RESEARCH   (United States)

^b HARBOR UCLA MEDICAL CENTER   (United States)

^c EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^d NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

Gene therapeutics; Growth hormone; Salivary glands; Systemic protein delivery

Indexed keywords

CREATINE; HUMAN GROWTH HORMONE; SOMATOMEDIN C; TRIACYLGLYCEROL; UREA;

ADENOVIRUS; ANIMAL EXPERIMENT; ARTICLE; GENE TRANSFER; GROWTH HORMONE BLOOD LEVEL; HORMONE ACTION; NONHUMAN; PRIORITY JOURNAL; RAT; SUBMANDIBULAR GLAND; UREA NITROGEN BLOOD LEVEL; VIRUS RECOMBINANT;

ADENOVIRIDAE; ANIMALIA;

EID: 0031952892     PISSN: 09697128     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.gt.3300622     Document Type: Article

References (27)

1. Bailey JE. Towards a science of metabolic engineering. Science 1991; 252: 1668-1675.
2. Tripathy SK et al. Stable delivery of physiologic levels of recombinant erythropoietin to the systemic circulation by intramuscular injections of replication-defective adenovirus. Proc Natl Acad Sci USA 1994; 91: 11557-11561.
3. Heartlein MW et al. Long-term production and delivery of human growth hormone in vivo. Proc Natl Acad Sci USA 1994; 91: 10967-10971.
4. Jorgensen JOL. Human growth hormone replacement therapy: pharmacological and clinical aspects. Endocrine Rev 1991; 12: 189-207.
5. Tai IT, Sun AM. Microencapsulation of recombinant cells: a new delivery system for gene therapy. FASEB J 1993; 7: 1061-1069.
6. Chen B-F et al. Long-term expression of the biologically active growth hormone in genetically modified fibroblasts after implantation into a hypophysectomized rat. Hum Gene Ther 1995; 6: 917-926.
7. Nagy JA et al. Systemic delivery of a recombinant protein by genetically modified mesothelial cells reseeded on the parietal peritoneal surface. Gene Therapy 1995; 2: 402-410.
8. Johnson OL et al. A month-long effect from a single injection of microencapsulated human growth hormone. Nature Med 1996; 2: 795-799.
9. Hurwitz DR et al. Systemic delivery of human growth hormone or human factor IX in dogs by reintroduced genetically modified autologous bone marrow stromal cells. Hum Gene Ther 1997; 8: 137-156.
10. Kagami H, O'Connell BC, Baum BJ. Evidence for the systemic delivery of a transgene product from salivary glands. Hum Gene Ther 1996; 7: 2177-2184.
11. Bramson JL, Graham FL, Gauldie J. The use of adenoviral vectors for gene therapy and gene transfer in vivo. Curr Opin Biotechnol 1995; 6: 590-595.
12. Yang Y et al. Cellular immunity to viral antigens limits E1-deleted adenoviruses for gene therapy. Proc Natl Acad Sci USA 1994; 91: 4407-4411.
13. Mastrangeli A et al. Direct in vivo adenovirus-mediated gene transfer to salivary glands. Am J Physiol 1994; 266: G1146-G1155.
14. 3/5 integrins and adenoviral infection in salivary glands. Lab Invest 1997; 77: 167-173.
15. He X et al. A polarized salivary cell monolayer useful for studying transepithelial fluid movement in vitro. Pflugers Archiv (in press).
16. Selden RF et al. Glucocorticoid regulation of human growth hormone expression in transgenic mice and transiently transfected cells. J Endocrinol 1989; 122: 49-60.
17. Upton Z et al. Characterization of serum-derived and recombinant rat IGF-1 and their use for measuring true concentrations of IGF-1 in rat plasma. J Endocrinol 1996; 146: 379-387.
18. Souza SC et al. A single arginine residue determines species specificity of the human growth hormone receptor. Proc Natl Acad Sci USA 1995; 92: 959-963.
19. Stratford-Perricaudet LD, Makeh I, Perricaudet M, Briand P. Widespread long-term gene transfer to mouse skeletal muscle and heart. J Clin Invest 1992; 90: 626-630
20. Ohno T et al. Gene therapy for vascular smooth muscle cell proliferation after arterial injury. Science 1994; 265: 781-784.
21. Huard J et al. The route of administration is a major determinant of the transduction efficiency of rat tissues by adenoviral recombinants. Gene Therapy 1995; 2: 107-115.
22. Guo ZS, Wang L-H, Eisensmith RC, Woo SLC. Evaluation of promoter strength for hepatic gene expression in vivo following adenovirus-mediated gene transfer. Gene Therapy 1996; 3: 802-810.
23. Parks RJ, Graham FL. A helper-dependent system for adenovirus vector production helps define a lower limit for efficient DNA packaging. J Virol 1997; 71: 3293-3298.
24. He X, Frank DP, Tabak LA. Establishment and characterization of 12 S adenoviral E1A immortalized rat submandibular gland epithelial cells. Biochem Biophys Res Commun 1990; 170: 336-343.
25. Delporte C et al. Adenovirus-mediated expression of aquaporin-5 in epithelial cells. J Biol Chem 1996; 271: 22070-22075.
26. Delporte C et al. Increased fluid secretion after adenoviral-mediated transfer of the aquaporin-1 cDNA to irradiated rat salivary glands. Proc Natl Acad Sci USA 1997; 94: 3268-3273.
27. Adesanya M, Redman RS, Baum BJ, O'Connell BC. Immediate inflammatory responses to adenovirus-mediated gene transfer in rat salivary glands. Hum Gene Ther 1996; 7: 1085-1093.